CVS Stock Recent News

CVS Health tapped industry veteran David Joyner to become CEO and turnaround the struggling business.

CVS Health Corp (NYSE:CVS) shares plunged more than 7% in early trade as the pharmaceutical chain announced it is replacing its CEO Karen Lynch with company veteran David Joyner, effective immediately. Joyner has most recently served as executive vice president of CVS Health and president of CVS Caremark, bringing 37 years of health care and pharmacy benefit management experience, CVS said on Friday.

Shares of CVS dropped by 10% on Friday morning, pacing what would be the company's worst loss in three years, after the company replaced its chief executive while cutting its earnings projections well below analyst expectations.

CNBC's Joe Kernen reports on the latest news.

CVS Health Corp.'s stock tumbled 10.5% early Friday, after the healthcare company announced leadership changes and lowered guidance for the fourth time this year, weighed down by challenges in its health-benefits business.

CVS to replace CEO Karen Lynch with exec David Joyner as profits, share price suffer

The healthcare provider named longtime executive David Joyner as its new CEO, succeeding Karen Lynch.

CVS Health/Morning Consult survey reveals most pharmacy teams and consumers say more care and services can and should be provided in community pharmacy Demand for pharmacy care is high, with 76% of consumers having at least one prescription for themselves or a person they care for Most consumers (81%) say they trust their local pharmacist and 83% say their pharmacist's recommendations are important to them WOONSOCKET, R.I. , Oct. 15, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today released the Rx Report: Transforming Community Pharmacy to Make Healthier Happen Together , which explores the ongoing evolution of community pharmacy as well as opportunities for the industry to keep pace with consumer expectations, better support the workforce and advance the pharmacy model to create a more viable, sustainable future for the industry.

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.

CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.